High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer
Author(s) -
Aziz Zaanan,
Claire Calmel,
Julie Henriques,
Magali Svrcek,
Hélène Blons,
Christèle DesboisMouthon,
Fatiha Merabtene,
Claire Goumard,
Yann Parc,
Brice Gayet,
Julien Taı̈eb,
Pierre Validire,
Christophe Louvet,
Jean–François Fléjou,
Yves Le Bouc,
Françoise Praz
Publication year - 2019
Publication title -
cellular oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.698
H-Index - 40
eISSN - 2211-3436
pISSN - 2211-3428
DOI - 10.1007/s13402-019-00484-6
Subject(s) - insulin like growth factor 1 receptor , medicine , immunohistochemistry , proportional hazards model , stage (stratigraphy) , colorectal cancer , oncology , cancer , protein expression , receptor , gastroenterology , pathology , growth factor , biology , gene , paleontology , biochemistry
The aim of this study was to investigate the association between expression of insulin-like growth factor-1 receptor (IGF1R) and its ligand, IGF-II, and disease-free survival (DFS) in patients with stage III colon cancer (CC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom